Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Research Areas
Products Related to Obesity, Appetite Control & Diabetes(354)
- GC49701Glycolithocholic Acid 3-sulfate (sodium salt)CAS: 64936-82-9Purity: >95.00%
A metabolite of glycolithocholic acid
- GC49815Oleuropein aglyconeCAS: 31773-95-2Purity: >98.00%
A polyphenol with diverse biological activities
- GC49833N-Boc SitagliptinCAS: 486460-23-5Purity: >98.00%
An intermediate in the synthesis of (-)-sitagliptin
- GC49844Stercobilin (hydrochloride)CAS: 5370-34-3Purity: >95.00%
A fecal pigment and metabolite of bilirubin
- GC498503-Epideoxycholic AcidCAS: 570-63-8Purity: >98.00%
A secondary bile acid and an epimer of deoxycholic acid
- GC49884Trigonelline-d3 (chloride)Purity: >99.00%
An internal standard for the quantification of trigonelline
- GC50190Fenretinide - d4CAS: 2118244-64-5Purity: >98%
Fenretinide - d4 is the deuterium labeled Fenretinide.
- GC52032Montbretin ACAS: 115712-92-0Purity: >98.00%
An acylated flavonol glycoside with antidiabetic activity
- GC5207110-oxo-12(Z)-Octadecenoic AcidCAS: 103521-29-5Purity: >95.00%
A metabolite of linoleic acid and an activator of TRPV1
- GC52135TesofensineCAS: 195875-84-4Purity: >95.00%
Tesofensine (NS-2330) is a triple monoamine reuptake inhibitor inducing a potent inhibition of the re-uptake process in the synaptic cleft of the neurotransmitters dopamine (DA; IC50=6.5 nM), norepinephrine (NE;IC50=1.7 nM), and serotonin (5-HT;IC50=11 nM), and with potentials as an anti-obesity agent.
- GC52214Nicotinamide riboside-d4 (triflate)Purity: >95.00%
An internal standard for the quantification of nicotinamide riboside
- GC52251Imidacloprid Impurity 1CAS: 105828-41-9Purity: >98.00%
A potential impurity in commercial preparations of imidacloprid
- GC52283L-Cysteine-15N-d3CAS: 1795787-05-1Purity: >99.00%
An internal standard for the quantification of L-cysteine
- GC52323L-Isoleucine-13C6CAS: 201740-82-1Purity: >95.00%
An internal standard for the quantification of L-isoleucine
- GC52331Lactoyl PhenylalanineCAS: 183241-73-8Purity: >99.50%
Lactoyl Phenylalanine is a secondary metabolite formed by the action of cytoplasmic non-specific dipeptidase (CNDP 2) between lactic acid and phenylalanine.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49671 | 2,3-Oxidosqualene | 7200-26-2 | >90.00% | |
An intermediate in the biosynthesis of sterols | ||||
| GC49701 | Glycolithocholic Acid 3-sulfate (sodium salt) | 64936-82-9 | >95.00% | |
A metabolite of glycolithocholic acid | ||||
| GC49798 | Glyphosine | 2439-99-8 | >98.00% | |
A plant growth regulator | ||||
| GC49815 | Oleuropein aglycone | 31773-95-2 | >98.00% | |
A polyphenol with diverse biological activities | ||||
| GC49833 | N-Boc Sitagliptin | 486460-23-5 | >98.00% | |
An intermediate in the synthesis of (-)-sitagliptin | ||||
| GC49844 | Stercobilin (hydrochloride) | 5370-34-3 | >95.00% | |
A fecal pigment and metabolite of bilirubin | ||||
| GC49850 | 3-Epideoxycholic Acid | 570-63-8 | >98.00% | |
A secondary bile acid and an epimer of deoxycholic acid | ||||
| GC49868 | D-α-Tocopheryl Quinone | 7559-04-8 | >98.00% | |
An oxidative metabolite of vitamin E | ||||
| GC49879 | Metformin hydroxy analog 2 | 98026-16-5 | >90.00% | |
An oxidation product of metformin | ||||
| GC49881 | Setmelanotide (trifluoroacetate salt) | - | >98.00% | |
A peptide agonist of MC4R | ||||
| GC49884 | Trigonelline-d3 (chloride) | - | >99.00% | |
An internal standard for the quantification of trigonelline | ||||
| GC50190 | Fenretinide - d4 | 2118244-64-5 | >98% | |
Fenretinide - d4 is the deuterium labeled Fenretinide. | ||||
| GC52032 | Montbretin A | 115712-92-0 | >98.00% | |
An acylated flavonol glycoside with antidiabetic activity | ||||
| GC52047 | Fustin | 20725-03-5 | >98.00% | |
| GC52071 | 10-oxo-12(Z)-Octadecenoic Acid | 103521-29-5 | >95.00% | |
A metabolite of linoleic acid and an activator of TRPV1 | ||||
| GC52125 | T-1095 | 209746-59-8 | >98.00% | |
T-1095 is a selective and orally active Na+-glucose cotransporter (SGLT) inhibitor with IC50s of 22.8 ?M and 2.3 ?M for human SGLT1 and SGLT2, respectively. | ||||
| GC52128 | AOD-9604 | 221231-10-3 | >98.00% | |
| GC52135 | Tesofensine | 195875-84-4 | >95.00% | |
Tesofensine (NS-2330) is a triple monoamine reuptake inhibitor inducing a potent inhibition of the re-uptake process in the synaptic cleft of the neurotransmitters dopamine (DA; IC50=6.5 nM), norepinephrine (NE;IC50=1.7 nM), and serotonin (5-HT;IC50=11 nM), and with potentials as an anti-obesity agent. | ||||
| GC52214 | Nicotinamide riboside-d4 (triflate) | - | >95.00% | |
An internal standard for the quantification of nicotinamide riboside | ||||
| GC52251 | Imidacloprid Impurity 1 | 105828-41-9 | >98.00% | |
A potential impurity in commercial preparations of imidacloprid | ||||
| GC52283 | L-Cysteine-15N-d3 | 1795787-05-1 | >99.00% | |
An internal standard for the quantification of L-cysteine | ||||
| GC52323 | L-Isoleucine-13C6 | 201740-82-1 | >95.00% | |
An internal standard for the quantification of L-isoleucine | ||||
| GC52331 | Lactoyl Phenylalanine | 183241-73-8 | >99.50% | |
Lactoyl Phenylalanine is a secondary metabolite formed by the action of cytoplasmic non-specific dipeptidase (CNDP 2) between lactic acid and phenylalanine. | ||||
| GC52380 | AOD-9604 (acetate) | - | >95.00% | |
A synthetic lipolytic peptide | ||||